CLL update 2022: A continuing evolution in care.
Blood Rev
; 54: 100930, 2022 07.
Article
in En
| MEDLINE
| ID: mdl-35151528
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Lymphocytic, Chronic, B-Cell
/
Lymphoma, B-Cell
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Blood Rev
Journal subject:
HEMATOLOGIA
Year:
2022
Document type:
Article
Country of publication: